![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2019
Jaworski, Janusz; Matucci-Cerinic, Marco; Schulze-Koops, Hendrik; Buch, Maya H.; Kucharz, Eugeniusz J.; Allanore, Yannick; Kavanaugh, Arthur; Young, Philip und Babic, Goran
(2019):
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study.
In: Arthritis Research & Therapy, Bd. 21, 130
2018
Matucci-Cerinic, Marco; Allanore, Yannick; Kavanaugh, Arthur; Buch, Maya H.; Schulze-Koops, Hendrik; Kucharz, Eugeniusz J.; Wöhling, Heike; Babic, Goran; Pötzl, Johann; Davis, Adanna und Schwebig, Arnd
(2018):
Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study.
In: Rmd Open, Bd. 4, Nr. 2
[PDF, 801kB]